August 29, 2022 — Amarin Corporation plc announced that new REDUCE-IT data show that VASCEPA/VAZKEPA (icosapent ethyl) significantly reduced cardiovascular (CV) events in patients with a history of smoking.Â
August 29, 2022 — ÂThe US Preventive Services Task Force (USPSTF) has issued a Recommendation Statement, relating to Statin Use for the Primary Prevention of Cardiovascular Disease in Adults, published in the Journal of American Medical Association (JAMA), August 23, 2022.
August 26, 2022 — COVID mRNA vaccines are associated with a decreased risk of death in patients with heart failure, according to research presented at ESC Congress 2022. The study also found that the vaccines were not associated
August 26, 2022 — Researchers in the Smidt Heart Institute at Cedars-Sinai are one step closer to identifying patients at highest risk for developing sudden cardiac death—an electrical malfunction in the heart that causes it to stop beating.Â
August 25, 2022 — The results of “A Phase 3, Open-label, Multicenter Study of Flurpiridaz (F18) Injection for Positron Emission Tomography (PET) Imaging Assessment of Myocardial Perfusion in Patients Referred for Invasive Angiography Because of Suspected Coronary Artery Disease (CAD)” will be presented for the first time atÂ
August 25, 2022 — Imperfect current propagation in the heart is at the root of most cardiac diseases. Thanks to a novel magnetocardiography technique developed in the MEXT Q-LEAP Flagship project with researchers from Tokyo Tech and the University of Tokyo, we can now image these currents at millimeter-scale resolutions.